{"id":"https://openalex.org/W4239693175","doi":"https://doi.org/10.1016/j.addr.2015.04.015","title":"Comment on: Inhaled antimicrobial therapy\u2014Barriers to effective treatment, by J. Weers, Inhaled antimicrobial therapy \u2014 Barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013","display_name":"Comment on: Inhaled antimicrobial therapy\u2014Barriers to effective treatment, by J. Weers, Inhaled antimicrobial therapy \u2014 Barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013","alternate_titles":[],"publication_year":2015,"publication_date":"2015-04-23","ids":{"openalex":"https://openalex.org/W4239693175","doi":"https://doi.org/10.1016/j.addr.2015.04.015","pmid":"https://pubmed.ncbi.nlm.nih.gov/25913564"},"language":"en","primary_location":{"id":"doi:10.1016/j.addr.2015.04.015","doi":"https://doi.org/10.1016/j.addr.2015.04.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.addr.2015.04.015","pdf_url":null,"source":{"id":"https://openalex.org/S114437232","display_name":"Advanced Drug Delivery Reviews","issn_l":"0169-409X","issn":["0169-409X","1872-8294"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advanced Drug Delivery Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4239693175"],"child_works_count":0,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090727487","display_name":"David C. Cipolla","orcid":"https://orcid.org/0000-0002-5773-4721","observed_orcids":["https://orcid.org/0000-0002-5773-4721"]},"institutions":[{"id":"https://openalex.org/I4210088092","display_name":"Aradigm (United States)","ror":"https://ror.org/000cxfw53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088092"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Cipolla","raw_affiliation_strings":["Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA. Electronic address: cipollad@aradigm.com","Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA. Electronic address: cipollad@aradigm.com","institution_ids":["https://openalex.org/I4210088092"]},{"raw_affiliation_string":"Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA","institution_ids":["https://openalex.org/I4210088092"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091473499","display_name":"Juergen Froehlich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088092","display_name":"Aradigm (United States)","ror":"https://ror.org/000cxfw53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088092"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juergen Froehlich","raw_affiliation_strings":["Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA","institution_ids":["https://openalex.org/I4210088092"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056500136","display_name":"Igor Gonda","orcid":"https://orcid.org/0000-0002-5206-794X","observed_orcids":["https://orcid.org/0000-0002-5206-794X"]},"institutions":[{"id":"https://openalex.org/I4210088092","display_name":"Aradigm (United States)","ror":"https://ror.org/000cxfw53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088092"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Igor Gonda","raw_affiliation_strings":["Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA","institution_ids":["https://openalex.org/I4210088092"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090727487"],"corresponding_institution_ids":["https://openalex.org/I4210088092"],"apc_list":{"value":5550,"currency":"USD","value_usd":5550},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"85","issue":null,"first_page":"e6","last_page":"e7"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-cystic-fibrosis-bronchiectasis","display_name":"non-cystic fibrosis bronchiectasis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pulmonary-exacerbations","display_name":"pulmonary exacerbations","score":0.9259999990463257},{"id":"https://openalex.org/keywords/liposomal-drug-delivery","display_name":"liposomal drug delivery","score":0.6299999952316284},{"id":"https://openalex.org/keywords/inhaled-antibiotics","display_name":"inhaled antibiotics","score":0.6620000004768372},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8870710134506226},{"id":"https://openalex.org/C2779379686","wikidata":"https://www.wikidata.org/wiki/Q32778","display_name":"Bronchiectasis","level":3,"score":0.854254961013794},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6416679620742798},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.62654709815979},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.5836880207061768},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.5699501037597656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5661539435386658},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5026514530181885},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.4920355975627899},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4014449119567871},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3507327437400818},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3362046480178833},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.3034122586250305},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09811133146286011},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012141","descriptor_name":"Respiratory Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D024901","descriptor_name":"Drug Resistance, Multiple, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.addr.2015.04.015","doi":"https://doi.org/10.1016/j.addr.2015.04.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.addr.2015.04.015","pdf_url":null,"source":{"id":"https://openalex.org/S114437232","display_name":"Advanced Drug Delivery Reviews","issn_l":"0169-409X","issn":["0169-409X","1872-8294"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advanced Drug Delivery Reviews","raw_type":"journal-article"},{"id":"pmid:25913564","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25913564","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advanced drug delivery reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1990308209","https://openalex.org/W1997115112","https://openalex.org/W2019367940","https://openalex.org/W2054666880","https://openalex.org/W2148928274","https://openalex.org/W2161605184","https://openalex.org/W2473682964","https://openalex.org/W2797993926"],"related_works":["https://openalex.org/W2909803788","https://openalex.org/W3156876600","https://openalex.org/W2910545013","https://openalex.org/W2970199429","https://openalex.org/W2161605184","https://openalex.org/W2032627466","https://openalex.org/W2941848109","https://openalex.org/W7135120373","https://openalex.org/W2903519408","https://openalex.org/W3122890371"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4239693175","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}
